BML Investment Partners, L.P. - 31 Dec 2024 SCHEDULE 13G/A Report for Achilles Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share (ACHL)

Filing Manager
BML Investment Partners, L.P.
Reporting Manager
BML Investment Partners, L.P.
Security
Achilles Therapeutics plc American Depositary Shares, each representing one ordinary share, nominal value of 0.001 per share
Symbol
ACHL
Shares outstanding
41,123,390 shares
Disclosed Ownership
4,100,002 shares
Ownership
9.97%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2025, 17:02:36 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BML Investment Partners, L.P. 9.97% 4,100,002 0 4,100,002 Braden M Leonard BML Capital Management, LLC its General Partner By: Braden M Leonard, its Managing Member